Modernatx, Inc.
Cambridge, MA
- UEI
- WJYNZ8AK2D47
- CAGE
- 6RP85
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 325 Binney St, Cambridge, MA 02142, USA
- Website
- modernatx.com
- Founded
- 2010
- Employees
- 1K-5K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Covid vaccines | Veterans Integrated Service Network 10 | $12,303 | |
| Deployable accelerated RNA technology (dart) | Defense Contract Management Agency | $30,195,163 | |
| 100M sars-COV-2 mrna-1273 vaccine doses | ACC Aberdeen Proving Ground | $8,204,906,278 | |
| Sars-COV-2 mrna-1273 vaccine | ACC Aberdeen Proving Ground | $0 | |
| Development of mrna vaccine to licensure for the prevention of covid-19. Clin 0001 - pre-award cost, clin 0002 -… | Office of the Assistant Secretary for Preparedness and Response | $1,754,345,480 |
About Modernatx, Inc.
Modernatx, Inc. is a manufacturer of pharmaceutical goods registered as a corporate entity in SAM.gov since 2012. The company specializes in pioneering messenger RNA therapeutics to produce human proteins or antibodies inside patient cells.
Through prime and subcontract awards, Modernatx has provided COVID-19 mRNA vaccines, accelerated RNA technology, mRNA-encoded antibodies against SARS-CoV-2, and scaled up domestic manufacturing capacity of mRNA vaccines. Major customers include the Department of Veterans Affairs, Defense Advanced Research Projects Agency, Department of the Army, and Department of Health and Human Services. Awards have been made on a firm fixed price, cost-plus-fixed-fee, and other transaction basis, spanning definitive contracts, purchase orders, and other transaction agreements. No set aside designations were indicated across the contract actions.
Modernatx has not received any prime federal grants, though it has participated as a subawardee designing and producing pre-clinical mRNA for coronavirus-related research under University of Texas Medical Branch prime awards.
The company also holds an other transaction IDV from the Defense Advanced Research Projects Agency to perform optimization work around a Phase I clinical trial of an mRNA construct encoding a SARS-CoV-2 antibody candidate. The IDV has a potential value of $7.9 million and aims to expedite COVID-19 therapeutic development.
Quick answers
What is Modernatx, Inc.'s UEI?
Modernatx, Inc.'s Unique Entity ID (UEI) in SAM.gov is WJYNZ8AK2D47.
What is Modernatx, Inc.'s CAGE code?
Modernatx, Inc.'s CAGE code is 6RP85.
What is Modernatx, Inc.'s primary NAICS code?
Modernatx, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Modernatx, Inc. located?
Modernatx, Inc.'s physical address in SAM.gov is 325 Binney St, Cambridge, MA 02142, USA.
Is Modernatx, Inc. registered in SAM.gov?
Yes. Modernatx, Inc.'s SAM.gov registration is active through March 22, 2027.
What is Modernatx, Inc.'s most recent federal award?
Modernatx, Inc.'s most recent federal contract award is Covid vaccines (36C25023P1813), from Veterans Integrated Service Network 10, on August 15, 2023.
On GovTribe
See Modernatx, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors